Archive for the ‘bipolar’ tag
Seroquel XR – different option
American Journal Of Psychiatry – December 1, 2009
Click here to see the details and full-size version in the gallery
This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.
New Geodon HCP campaign
Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotic
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: acute agitation in schizophrenic patients and acute treatment of mania and mixed states associated with bipolar disorder
Target: Healthcare Professionals (HCP)
Tagline: See me for who I can be
Medium: Print ad
Size/duration: single-page
Publication/Aired: October and November 2009
To see all of this brand’s ads on AdPharm, click here
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Geodon
Control acute agitation with Geodon for injection
In schizophrenia… Rapid improvement with low EPS
Ziprasidone (marketed as Geodon, Zeldox by Pfizer) was the fifth atypical antipsychotic to gain FDA approval (February 2001). In the United States, Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania and mixed states associated with bipolar disorder. The brand name Geodon has been suggested to bring to mind the phrase 'down (don) to earth (geo)' referring to the goals of the medication.
The oral form of ziprasidone is the hydrochloride salt, ziprasidone hydrochloride. The intramuscular form, on the other hand, is the mesylate salt, ziprasidone mesylate trihydrate, and is provided as a lyophilized powder.
From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)
Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotics
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: Schizophrenia
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007
To see all of this brand's ads on AdPharm, click here
2 views
Aug 23, 2009
Visit AdPharm.net for more pharmaceutical ads
Geodon
Control acute agitation with Geodon for injection
In schizophrenia… Rapid improvement with low EPS
Ziprasidone (marketed as Geodon, Zeldox by Pfizer) was the fifth atypical antipsychotic to gain FDA approval (February 2001). In the United States, Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania and mixed states associated with bipolar disorder. The brand name Geodon has been suggested to bring to mind the phrase 'down (don) to earth (geo)' referring to the goals of the medication.
The oral form of ziprasidone is the hydrochloride salt, ziprasidone hydrochloride. The intramuscular form, on the other hand, is the mesylate salt, ziprasidone mesylate trihydrate, and is provided as a lyophilized powder.
From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)
Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotics
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: Schizophrenia
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007
To see all of this brand's ads on AdPharm, click here
0 views
Aug 23, 2009
Seroquel XR – For the Ups. For the Downs.
Seroquel XR
The first treatment in Canada for both poles of bipolar disorder.
For the Ups. For the Downs.
Souce: Journal of Psychiatry and Neuroscience, January 2009.
To see other Seroquel ads on AdPharm, click here.
